We show that activated Wnt signalling is correlated with immune suppression in primary PC, and suggest that activated Wnt/β-catenin, MMR, high INIF and the CD8+/FOXP3+ ratio should be explored as predictive biomarkers for immunotherapeutics in prostate cancer. This evidence concerns the gene FOXP3 and prostate cancer.